Minovia Gets $350K Grant for Blood Biomarker Research
Minovia Therapeutics has secured a $350,000 grant from the philanthropic group Countdown for a Cure to advance blood-based mitochondrial...
eClinical Tech News
YD Bio Announces Successful NASDAQ Listing and Combination
YD Bio Limited has completed its business combination with Breeze Holdings Acquisition Corp. and will begin trading on the...
Cytomed’s Acquisition Unlocks Auto-Immune Disease Focus
Cytomed Therapeutics has expanded clinical-scale natural killer cells from cord blood units cryopreserved for more than a decade and...
Can-Fite Reports H1 2025 Financial, Clinical Results
Can-Fite Biopharma reported mid-year 2025 results alongside several clinical updates: its Phase 2a study of namodenoson in advanced pancreatic...
Nurexone Biologic Inc. Reveals Q2 2025 Financial Results
Nurexone Biologic reported its second-quarter 2025 results and advanced a series of steps toward first-in-human testing of ExoPTEN, its...
FDA Approves Idorsia’s Tryvio for Systemic Hypertension
Idorsia is sharpening the commercial and scientific positioning of Tryvio (aprocitentan), releasing an on-demand webcast that frames the first-in-class...
MannKind to Acquire scPharma, Accelerating Growth
MannKind Corporation’s acquisition of scPharmaceuticals for up to $360 million, including milestone-based contingent value rights (CVRs), marks a decisive...
Proxygen & EPFL Team Up for AI Glue Discovery
Proxygen, a leader in molecular glue degrader discovery and development, has partnered with the Swiss Federal Institute of Technology...
Pharmather Announces FDA Approval of Ketarx™ (Ketamine)
PharmaTher Holdings Ltd. is aggressively pursuing a dual-pronged strategy centered around its recently FDA-approved ketamine product, KETARx™. The company...
Odyssey Health to Advance Life-Saving Choking Rescue Device
Odyssey Health, a technology and asset acquisition company, is advancing the development of its patented Save a Life (SAL)...